David Byram
General Counsel at BRAEBURN INC.
Profile
David Byram is currently working as the VP-Market Access & State Government Affairs at Braeburn Pharmaceuticals SPRL and Braeburn, Inc. He has previously worked as the Senior Vice President-Commercial Affairs at Orexo AB and as the Chief Commercial Officer at StageZero Life Sciences Ltd.
Mr. Byram completed his undergraduate degree from Indiana University.
David Byram active positions
Companies | Position | Start |
---|---|---|
BRAEBURN INC. | General Counsel | - |
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | General Counsel | - |
Former positions of David Byram
Companies | Position | End |
---|---|---|
OREXO AB | Corporate Officer/Principal | - |
STAGEZERO LIFE SCIENCES LTD. | Corporate Officer/Principal | - |
Training of David Byram
Indiana University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
STAGEZERO LIFE SCIENCES LTD. | Health Technology |
OREXO AB | Health Technology |
Private companies | 2 |
---|---|
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Health Technology |
Braeburn, Inc.
Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
- Stock Market
- Insiders
- David Byram